B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KCNK5

MOLECULAR TARGET

potassium two pore domain channel subfamily K member 5

UniProt: O95279NCBI Gene: 86451 compounds

KCNK5 (potassium two pore domain channel subfamily K member 5) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KCNK5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Quinidine0.691

About KCNK5 as a Drug Target

KCNK5 (potassium two pore domain channel subfamily K member 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented KCNK5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KCNK5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.